bioM&eaigu;rieux: Launch of BIOFIRE® MYCOPLASMA Test for Mycoplasma Detection in Biopharmaceutical Products
(WorldNews France)

bioM&eaigu;rieux: Launch of BIOFIRE® MYCOPLASMA Test for Mycoplasma Detection in Biopharmaceutical Products 16 Jul 2020 07:00 CEST Company Name BIOMERIEUX ISN FR0013280286 Market Euronext Symbol BIM Regulatory News: bioM&eaigu;rieux (Paris:BIM), a world leader in the field of in vitro diagnostics, has announced the launch of BIOFIRE® MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biotherapeutics (antibodies, hormones, cell and gene therapies, etc.), the most vibrant sector in the pharmaceutical industry. Mycoplasmas are bacteria found during biopharmaceutical manufacturing. Some species of mycoplasma cause respiratory and genital infections, thus representing...